Hospital
Samaritan Medical Center
Samaritan Medical Center was paid $67.56M by Medicaid between Jan 2018 and Dec 2024, across 406 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 19% of everything it billed.
33Billing provider infoSAMARITAN MEDICAL CENTER
WATERTOWN, NY 13601
WATERTOWN, NY 13601
33aNPI1598713745assigned 05/04/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$67.56M
24GClaims1,042,134
24DCodes billed406
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in New York
Rank by total paid#23 of 231
Median peer was paid$561K
This provider vs. median120×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,941 | $618K | |
| 2019 | 77,737 | $3.18M | |
| 2020 | 195,119 | $8.71M | |
| 2021 | 209,141 | $9.60M | |
| 2022 | 186,491 | $16.50M | |
| 2023 | 203,746 | $17.58M | |
| 2024incomplete | 157,959 | $11.38M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 19% | 78,456 | 65,444 | $12.53M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.7% | 65,058 | 59,783 | $5.21M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 7.2% | 30,150 | 20,306 | $4.89M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.6% | 41,985 | 39,596 | $3.80M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 3.9% | 18,780 | 17,480 | $2.66M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.3% | 16,442 | 15,783 | $2.20M |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.2% | 6,084 | 5,446 | $1.50M |
| 36415 | Collection of venous blood by venipuncture | 2.2% | 47,980 | 42,063 | $1.47M |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 1.9% | 780 | 768 | $1.26M |
| 70450 | Computed tomography, head or brain; without contrast material | 1.7% | 3,767 | 3,678 | $1.17M |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.6% | 8,317 | 3,156 | $1.06M |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.5% | 21,598 | 18,686 | $1.05M |
394 more codes
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.4% | 3,943 | $974K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.4% | 3,969 | $933K |
| 80053 | Comprehensive metabolic panel | 1.3% | 38,481 | $907K |
| 99285 | Emergency room visit (most serious) | 1.2% | 6,191 | $784K |
| G0397 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes | 1.1% | 5,186 | $724K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1.1% | 553 | $711K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 1.0% | 366 | $701K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 825 | $674K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 4,894 | $577K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 3,861 | $575K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 4,784 | $574K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 3,172 | $556K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 2,329 | $552K |
| 93976 | <1% | 1,864 | $536K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 1,596 | $535K |
| 81025 | <1% | 2,446 | $528K | |
| 59025 | Fetal non-stress test | <1% | 2,289 | $525K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 12,672 | $524K |
| 87486 | <1% | 11,774 | $518K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 6,234 | $517K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 2,123 | $495K |
| D9223 | Deep sedation/general anesthesia - each subsequent 15 minute increment | <1% | 494 | $486K |
| 17110 | <1% | 1,830 | $485K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 7,119 | $453K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 2,185 | $452K |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | <1% | 6,853 | $402K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 9,241 | $399K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 11,758 | $392K |
| 11102 | <1% | 703 | $391K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,476 | $379K |
| 86850 | <1% | 5,206 | $346K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 2,201 | $317K |
| 87631 | <1% | 4,293 | $314K | |
| 80047 | <1% | 4,835 | $306K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,108 | $276K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,598 | $268K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 3,697 | $261K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 107 | $257K |
| 87581 | <1% | 11,776 | $247K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 1,080 | $239K |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 319 | $233K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 964 | $225K |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | <1% | 2,075 | $221K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 704 | $207K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 4,035 | $206K |
| 51798 | <1% | 561 | $205K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 5,504 | $203K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 25,398 | $195K |
| 80076 | <1% | 15,459 | $194K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,446 | $194K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,406 | $175K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,174 | $172K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,379 | $172K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 3,946 | $163K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 15,782 | $150K |
| 80061 | Lipid panel | <1% | 20,098 | $138K |
| 84439 | <1% | 13,825 | $129K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 2,672 | $122K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 38,848 | $107K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 349 | $102K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,073 | $94K |
| 76801 | <1% | 954 | $91K | |
| 97161 | <1% | 1,036 | $90K | |
| 71250 | <1% | 1,043 | $90K | |
| 99201 | <1% | 729 | $85K | |
| 90715 | <1% | 2,063 | $85K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 2,422 | $85K |
| H0001 | Alcohol and/or drug assessment | <1% | 557 | $83K |
| 87428 | <1% | 551 | $81K | |
| 88142 | <1% | 3,318 | $78K | |
| 86901 | <1% | 5,047 | $77K | |
| 83880 | <1% | 2,212 | $73K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 4,199 | $71K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 10,258 | $71K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 11,052 | $66K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 587 | $64K |
| 82728 | <1% | 5,099 | $62K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 868 | $61K |
| 90682 | <1% | 1,966 | $61K | |
| 87070 | <1% | 7,574 | $59K | |
| 87810 | <1% | 1,986 | $59K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 560 | $58K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 589 | $58K |
| 96415 | <1% | 97 | $57K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 1,203 | $57K |
| 94010 | <1% | 2,783 | $56K | |
| 86900 | <1% | 4,821 | $56K | |
| 97010 | <1% | 2,284 | $55K | |
| 82607 | <1% | 4,298 | $55K | |
| S9480 | Intensive outpatient psychiatric services, per diem | <1% | 515 | $53K |
| G0378 | Hospital observation service, per hour | <1% | 669 | $53K |
| 93971 | <1% | 645 | $52K | |
| 36591 | <1% | 1,940 | $51K | |
| 76830 | Ultrasound, transvaginal | <1% | 1,541 | $50K |
| 94726 | <1% | 511 | $49K | |
| 90686 | <1% | 803 | $46K | |
| 17000 | <1% | 147 | $45K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,858 | $43K |
| 85027 | <1% | 13,867 | $43K | |
| 86780 | <1% | 3,625 | $43K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 905 | $42K |
| 86803 | <1% | 4,585 | $41K | |
| 94060 | <1% | 532 | $41K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 5,998 | $41K |
| 76775 | <1% | 865 | $41K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,860 | $40K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 812 | $40K |
| 87507 | <1% | 244 | $39K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 16 | $39K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,874 | $38K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,219 | $38K |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | <1% | 272 | $37K |
| 12001 | <1% | 86 | $37K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 3,845 | $36K |
| 84403 | <1% | 1,377 | $36K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 526 | $36K |
| 87340 | <1% | 3,851 | $36K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 106 | $35K |
| 99406 | <1% | 497 | $34K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 105 | $34K |
| 87522 | Neg quan hep c or qual rna | <1% | 725 | $33K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 229 | $31K |
| 76000 | <1% | 179 | $31K | |
| 70491 | <1% | 124 | $31K | |
| 71271 | <1% | 1,109 | $31K | |
| 72141 | <1% | 102 | $30K | |
| 84153 | <1% | 1,530 | $29K | |
| 82746 | <1% | 2,666 | $29K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 834 | $28K |
| 87186 | <1% | 4,922 | $28K | |
| 11900 | <1% | 84 | $28K | |
| 86762 | <1% | 1,869 | $27K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 236 | $27K |
| 83655 | <1% | 1,776 | $27K | |
| 83970 | <1% | 623 | $27K | |
| 81001 | <1% | 12,042 | $26K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 948 | $25K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 13 | $24K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 515 | $24K |
| 70486 | <1% | 288 | $24K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,260 | $24K |
| 87088 | <1% | 3,200 | $24K | |
| 93970 | <1% | 57 | $23K | |
| 84702 | <1% | 4,106 | $23K | |
| 82803 | <1% | 1,174 | $23K | |
| 99460 | <1% | 503 | $22K | |
| 86140 | <1% | 6,257 | $22K | |
| 86480 | <1% | 361 | $21K | |
| 87081 | <1% | 3,974 | $21K | |
| 85610 | <1% | 5,492 | $21K | |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | <1% | 57 | $21K |
| 83550 | <1% | 4,360 | $20K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 722 | $20K |
| 87077 | <1% | 2,350 | $20K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 495 | $20K |
| 11045 | <1% | 18 | $18K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 363 | $18K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,196 | $17K |
| 83735 | <1% | 4,630 | $17K | |
| 77065 | Tomosynthesis, mammo | <1% | 235 | $17K |
| 52000 | <1% | 13 | $16K | |
| 87850 | <1% | 1,277 | $16K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 99 | $16K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,773 | $15K |
| 76642 | <1% | 817 | $15K | |
| 86038 | <1% | 2,563 | $14K | |
| 86665 | <1% | 906 | $14K | |
| 82043 | <1% | 2,760 | $14K | |
| 73564 | <1% | 1,558 | $14K | |
| 82784 | <1% | 1,417 | $14K | |
| 96367 | <1% | 149 | $14K | |
| 76820 | <1% | 1,032 | $14K | |
| 72110 | <1% | 860 | $13K | |
| 94729 | <1% | 516 | $13K | |
| 76536 | <1% | 562 | $13K | |
| 86617 | <1% | 869 | $13K | |
| 87521 | Neg quan hep c or qual rna | <1% | 327 | $12K |
| 77066 | Tomosynthesis, mammo | <1% | 214 | $12K |
| 88304 | <1% | 311 | $12K | |
| 86618 | <1% | 777 | $11K | |
| 85652 | <1% | 6,275 | $11K | |
| 85055 | <1% | 328 | $11K | |
| 87505 | <1% | 147 | $11K | |
| 86003 | <1% | 320 | $11K | |
| 86376 | <1% | 745 | $10K | |
| 86431 | <1% | 2,058 | $10K | |
| H0038 | Self-help/peer services, per 15 minutes | <1% | 176 | $10K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 89 | $10K |
| 82950 | <1% | 1,526 | $10K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 95 | $10K |
| 76857 | <1% | 195 | $9K | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | <1% | 159 | $9K |
| 85730 | <1% | 2,906 | $9K | |
| 99401 | <1% | 61 | $9K | |
| 73630 | <1% | 1,508 | $8K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,813 | $8K |
| 99385 | <1% | 77 | $8K | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 109 | $8K |
| 73030 | <1% | 1,111 | $8K | |
| 77080 | <1% | 154 | $8K | |
| 73610 | <1% | 1,435 | $8K | |
| 84591 | <1% | 80 | $8K | |
| 11104 | <1% | 12 | $7K | |
| 74018 | <1% | 1,422 | $7K | |
| 83001 | <1% | 372 | $7K | |
| 83002 | <1% | 374 | $7K | |
| 86705 | <1% | 746 | $6K | |
| 73110 | <1% | 1,038 | $6K | |
| 73130 | <1% | 1,182 | $6K | |
| 97803 | <1% | 267 | $6K | |
| 88300 | <1% | 1,226 | $6K | |
| 20552 | <1% | 138 | $6K | |
| 86235 | <1% | 932 | $6K | |
| 90673 | <1% | 132 | $6K | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,917 | $6K |
| 84550 | <1% | 1,304 | $6K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 94 | $6K |
| 83540 | <1% | 1,131 | $6K | |
| 70544 | <1% | 12 | $6K | |
| 84146 | <1% | 291 | $6K | |
| 86664 | <1% | 446 | $5K | |
| 86709 | <1% | 704 | $5K | |
| 84402 | <1% | 214 | $5K | |
| 99442 | <1% | 63 | $5K | |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | <1% | 25 | $5K |
| 83690 | <1% | 5,564 | $5K | |
| D7111 | <1% | 14 | $5K | |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | <1% | 412 | $5K |
| 82570 | <1% | 1,000 | $5K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 32 | $5K |
| 72131 | <1% | 27 | $5K | |
| 82550 | <1% | 4,915 | $4K | |
| 86706 | <1% | 541 | $4K | |
| 73502 | <1% | 677 | $4K | |
| C8903 | Magnetic resonance imaging with contrast, breast; unilateral | <1% | 36 | $4K |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | <1% | 71 | $4K |
| 86160 | <1% | 401 | $4K | |
| 87902 | <1% | 13 | $4K | |
| 87590 | <1% | 528 | $4K | |
| 87490 | <1% | 528 | $4K | |
| 84425 | <1% | 310 | $4K | |
| 82565 | <1% | 591 | $4K | |
| 93000 | <1% | 394 | $4K | |
| 87430 | <1% | 646 | $4K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,059 | $4K |
| 84207 | <1% | 124 | $3K | |
| 86364 | <1% | 420 | $3K | |
| 77062 | <1% | 50 | $3K | |
| 10060 | <1% | 12 | $3K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 219 | $3K |
| 93242 | <1% | 27 | $3K | |
| 77002 | <1% | 13 | $3K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 143 | $3K |
| 84156 | <1% | 877 | $3K | |
| 83615 | <1% | 881 | $3K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 81 | $3K |
| 90732 | <1% | 66 | $3K | |
| 84703 | <1% | 3,455 | $3K | |
| 90734 | <1% | 90 | $3K | |
| 99386 | <1% | 24 | $3K | |
| 80069 | <1% | 217 | $3K | |
| 88307 | <1% | 40 | $3K | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 82 | $3K |
| H0050 | Alcohol and/or drug services, brief intervention, per 15 minutes | <1% | 47 | $2K |
| 82247 | <1% | 424 | $2K | |
| 83525 | <1% | 205 | $2K | |
| 86800 | <1% | 184 | $2K | |
| 11200 | <1% | 12 | $2K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 13 | $2K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 25 | $2K |
| 81000 | <1% | 772 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,666 | $2K |
| 84484 | <1% | 3,754 | $2K | |
| 82150 | <1% | 704 | $2K | |
| 81374 | <1% | 50 | $2K | |
| 76870 | <1% | 68 | $2K | |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 36 | $2K |
| 90670 | <1% | 75 | $2K | |
| 84436 | <1% | 420 | $2K | |
| 31575 | <1% | 33 | $2K | |
| 87205 | <1% | 677 | $2K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 14 | $2K |
| 86255 | <1% | 293 | $2K | |
| 84100 | <1% | 429 | $1K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 64 | $1K |
| 84165 | <1% | 201 | $1K | |
| 81596 | <1% | 25 | $1K | |
| 87040 | <1% | 2,090 | $1K | |
| 93246 | <1% | 12 | $1K | |
| 85379 | <1% | 644 | $1K | |
| 84481 | <1% | 160 | $1K | |
| 82248 | <1% | 261 | $1K | |
| J1453 | Injection, fosaprepitant, 1 mg | <1% | 21 | $1K |
| 77334 | <1% | 17 | $1K | |
| 87536 | <1% | 12 | $1K | |
| 80164 | <1% | 124 | $1K | |
| 83993 | <1% | 94 | $999.96 | |
| 86200 | <1% | 123 | $984.71 | |
| 82553 | <1% | 3,591 | $928.71 | |
| 72100 | <1% | 94 | $891.61 | |
| 77061 | <1% | 15 | $888.84 | |
| 97597 | <1% | 27 | $850.82 | |
| 54150 | <1% | 12 | $848.82 | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 14 | $832.38 |
| 86258 | <1% | 114 | $827.94 | |
| 86256 | <1% | 14 | $819.76 | |
| 86704 | <1% | 81 | $792.82 | |
| 83605 | <1% | 1,880 | $769.43 | |
| 90648 | <1% | 42 | $749.70 | |
| 86308 | <1% | 319 | $731.89 | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | <1% | 210 | $718.48 |
| 81002 | <1% | 1,029 | $718.47 | |
| 73140 | <1% | 198 | $715.37 | |
| D1120 | Dental cleaning, child | <1% | 14 | $696.57 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 1,284 | $605.58 |
| 86663 | <1% | 67 | $595.55 | |
| 72082 | <1% | 51 | $587.78 | |
| G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | <1% | 67 | $586.36 |
| D1206 | Topical application of fluoride varnish | <1% | 13 | $582.09 |
| 84480 | <1% | 108 | $575.76 | |
| 86360 | <1% | 12 | $563.76 | |
| 84460 | <1% | 137 | $539.63 | |
| 82977 | <1% | 108 | $518.66 | |
| 73590 | <1% | 172 | $491.73 | |
| 84154 | <1% | 24 | $488.88 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 468 | $477.43 |
| D0272 | Bitewings - two radiographic images | <1% | 24 | $438.83 |
| 86162 | <1% | 29 | $436.90 | |
| 84450 | <1% | 111 | $429.41 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,771 | $419.49 |
| 85046 | <1% | 226 | $378.95 | |
| 84520 | <1% | 90 | $374.31 | |
| 85018 | <1% | 116 | $369.45 | |
| 84446 | <1% | 24 | $368.25 | |
| 86708 | <1% | 38 | $354.58 | |
| 85049 | <1% | 225 | $336.35 | |
| 36600 | <1% | 12 | $322.56 | |
| 86147 | <1% | 21 | $314.17 | |
| 73080 | <1% | 84 | $307.20 | |
| 80143 | <1% | 1,584 | $298.00 | |
| 80503 | <1% | 13 | $277.00 | |
| 93041 | <1% | 3,405 | $276.69 | |
| 82670 | <1% | 12 | $270.63 | |
| 74021 | <1% | 112 | $264.00 | |
| 82077 | <1% | 1,916 | $263.24 | |
| 86225 | <1% | 50 | $259.99 | |
| 99417 | Prolong home eval add 15m | <1% | 12 | $248.99 |
| 82172 | <1% | 16 | $223.02 | |
| 70310 | <1% | 85 | $222.24 | |
| 72072 | <1% | 15 | $216.00 | |
| 90723 | <1% | 12 | $214.20 | |
| 88302 | <1% | 43 | $212.16 | |
| 86231 | <1% | 27 | $194.50 | |
| 82105 | <1% | 25 | $158.99 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 566 | $158.05 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 186 | $147.09 |
| 90658 | <1% | 12 | $142.92 | |
| 82378 | <1% | 28 | $142.31 | |
| 83010 | <1% | 13 | $142.09 | |
| 99441 | <1% | 16 | $137.72 | |
| 83520 | <1% | 12 | $129.14 | |
| 86677 | <1% | 15 | $119.95 | |
| 84479 | <1% | 39 | $105.12 | |
| 82951 | <1% | 16 | $102.60 | |
| 87808 | <1% | 33 | $100.71 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,605 | $97.97 |
| 94760 | <1% | 1,507 | $97.14 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,118 | $95.71 |
| 81015 | <1% | 174 | $90.07 | |
| G0008 | Administration of influenza virus vaccine | <1% | 15 | $87.09 |
| 84155 | <1% | 28 | $80.81 | |
| 80178 | <1% | 13 | $70.40 | |
| 71101 | <1% | 13 | $52.50 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,307 | $51.15 |
| 82140 | <1% | 13 | $43.71 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,983 | $32.39 |
| 87210 | <1% | 443 | $29.11 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 121 | $26.83 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,659 | $21.90 |
| 82952 | <1% | 15 | $19.60 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 86 | $17.94 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 172 | $13.40 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 206 | $12.68 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,131 | $12.48 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 17 | $8.16 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 12 | $6.94 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 252 | $6.53 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 205 | $5.51 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 29 | $0.12 |
| 59425 | 0% | 140 | $0.00 | |
| 82726 | 0% | 33 | $0.00 | |
| 87807 | 0% | 36 | $0.00 | |
| 96376 | 0% | 48 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHOCHGRAF, CHRIS (DIRECTOR OF REVENUE CYCLE)
| Provider | Location | Paid |
|---|---|---|
| Samaritan Medical Center | Watertown, NY | $149K |
| Samaritan Keep Nursing Home INC | Watertown, NY | $53K |
| Samaritan Senior Village, INC. | Watertown, NY | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.